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Abstract  
 
Background 
People diagnosed with schizophrenia have significant difficulty accurately recognising 
emotions expressed by others. This may generate anomalous experiences which, if 
misinterpreted, could contribute to experiences of social defeat, psychotic symptoms and 
reduced social functioning. It remains unclear whether this impairment is responsive to non-
pharmacological intervention, or what the effect of modifying it is.  
 
Methods 
We did a systematic review and meta-analysis to examine whether and to what extent facial 
affect recognition impairments can be improved by psychological intervention and, if so, 
whether this leads to improvements in psychotic symptoms and social functioning.  
 
Results 
A total of 8 randomised controlled trials (RCTs) consisting of 300 participants were included. 
Focused yet brief psychological interventions led to very large improvements in facial affect 
recognition ability in psychosis [k=8, N=300, g=1.26, 95% Confidence Interval (CI) 0.92, 
1.60, I
2
 41%]. Early evidence suggests this may cause large improvements in social 
functioning (k=3, N=109, g=0.98, 95% CI 0.37, 1.36, I
2 
38%), but not psychotic symptoms. 
 
Conclusions 
Facial affect recognition difficulties in schizophrenia are highly responsive to psychological 
interventions designed to improve them, and there is early evidence that this may lead to 
large gains in social functioning for this group - but not symptoms. A large-scale high-quality 
RCT with longer-term follow-up period is now required to overcome the limitations of the 
existing evidence. 
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1. Introduction 
 
People diagnosed with schizophrenia report significantly reduced social functioning (APA, 
1994; Bellack et al., 1990). This may be related to difficulties in ‘social cognition’ 
(Addington et al., 2006; Penn et al., 1997), which refers to the way in which we understand, 
perceive and interpret our social world (Penn et al., 1997) and consists of various components 
including facial affect recognition, ‘theory of mind’, social perception and our ability to make 
appropriate attributions for events. These have a direct impact on one’s ability to interact 
socially (Couture et al., 2006) and problems in any one of these areas may have a large 
impact on a person’s day to day functioning (Irani et al., 2012).  
 
Indeed, there is robust and consistent evidence that patients with a diagnosis of schizophrenia 
have significant difficulties in recognising facial expressions of emotion  (Kohler et al., 2009) 
and that these difficulties may be associated with reduced social functioning (Hooker & Park, 
2002; Irani et al., 2012). These difficulties appear to be unrelated to the phase of the disorder 
(Penn & Combs, 2000), are not remediated by antipsychotic medication (Addington & 
Addington, 1998), are not simply a reflection of general cognitive impairment (Barkhof et al., 
2015) and appear to exist prior to onset of the illness (Gibson et al., 2010). The real-world 
impact of these difficulties has been illustrated by their association with poor performance in 
social role plays (Mueser et al., 1996), although a recent study using experience sampling has 
challenged this claim (Janssens et al., 2012). Some studies suggest that people with 
schizophrenia have particular difficulties in recognising negative facial expressions 
(Demirbuga et al., 2013; Hofer et al., 2009), although the cause and consequences of this 
remain unclear.  
 
Impaired facial affect recognition may also contribute to both negative and positive 
symptoms. They may be implicated in asociality (Poole et al., 2000), impaired emotional 
expression (Gaebel & Wölwer, 1992) and anhedonia (Green & Walker, 1986; Gur et al., 
2006; Neale et al., 1985). Difficulty in interpreting emotions correctly could generate 
confusion regarding the intentions of others, which may lead to a confusing social world for 
people with psychosis (Couture et al., 2005). Attempting to make sense of this may therefore 
trigger an increase in positive symptoms such as paranoia (Garety et al., 2001; Green & 
Phillips, 2004; Couture et al., 2005) and delusional ideation (Arguedas et al., 2006).  
 
Various interventions have been devised to try to improve facial affect recognition difficulties 
in psychosis. Kurtz and Richardson carried out a meta-analysis of social cognitive 
remediation programmes, and reported a moderate to large effect size (d=0.78) for improved 
identification of facial expressions and a large effect size (d=1.01) for improved 
discrimination of facial expressions (Kurtz & Richardson, 2012). Furthermore when looking 
at functioning within the community or institution, a large effect size was also found (d=0.78) 
after completion of the programme. Although this meta-analysis provides support for the 
efficacy of interventions to improve these difficulties, the included programmes varied 
between ones which solely focused on targeting facial affect recognition, others with a 
broader focus on social cognition in general, which includes addressing theory of mind 
deficits and social skills training in addition to facial affect recognition and some treatment 
programmes which targeted cognition and social cognition.  
 
A previous meta-analysis by Fett et al., (2011) demonstrated that different domains of social 
cognitive training programmes have different effects on components of social cognition and 
functioning. They therefore recommend that treatments targeting specific domains be 
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examined to obtain a truer picture of the key active domains of social cognition that improve 
social functioning. No meta-analysis has specifically investigated the benefit of programmes 
solely focused on treating and improving facial affect recognition. Whether facial affect 
recognition training (FRT) improves facial affect recognition ability in people with 
schizophrenia and, if so, whether this has any important benefits on other outcomes of value, 
therefore remains unclear.  
 
The aim of the this study was to address this gap in the evidence, and conduct a systematic 
review and meta-analysis to determine whether FRT programmes do improve facial affect 
recognition ability in schizophrenia and, if so, to what extent. The effect of FRT on social 
functioning and psychotic symptoms will also be assessed, since impaired facial recognition 
ability is hypothesised to be involved in causing or maintaining these problems. If FRT 
causes improvements in these domains, then it would be a valuable treatment for promoting 
recovery in psychosis. 
 
2. Method 
 
2.1.Search Strategy 
A systematic review of the literature was conducted in accordance with PRISMA (Moher et 
al., 2009) and AMSTAR (Shea et al., 2007) guidelines. A search of the following electronic 
databases was carried out in March 2015:- Medline, Embase, PsychInfo and Web Science. 
All years available were searched, using the following terms: ‘facial affect recognition, facial 
emotion recognition, facial affect recognition training, social cognition, emotion perception, 
schizophrenia’ and ‘schizoaffective’. Additionally in order to identify any unpublished 
studies the US government clinical trials register (clinicaltrials.gov), European Union clinical 
trials register (clinicaltrials-register.eu), World Health Organisation (apps.who.int/trialsearch) 
and Current Controlled Trials Ltd (controlled-trials.com) were all searched in May 2015. 
Reference sections within the articles which met the inclusion criteria were also searched by 
hand to identify any further papers. 
 
2.2.Inclusion Criteria 
Intervention studies involving adult (18 years+) participants with a diagnosis of non-affective 
psychotic illness (schizophrenia, brief psychotic disorder) or schizoaffective disorder were 
eligible for inclusion. Eligible studies required at least 50% of participants to have a 
diagnosis of non-affective psychosis. Studies where 50% or more participants had learning 
disability, predominantly substance induced psychosis, or organic brain damage were 
excluded. Studies which took place in a variety of settings such as inpatient and outpatient 
were included providing the other criteria were met. Eligible studies had to assess the effect 
of interventions that were specifically designed to improve facial affect recognition. Studies 
were only included if more than 50% of the intervention was judged to specifically address 
facial affect recognition. This was determined by accessing the intervention manual or 
description, and calculating a percentage of the total time dedicated within the programme to 
facial affect recognition training. In order to minimise risk of bias, only randomised 
controlled studies were included in the main meta-analyses. We planned to use narrative 
synthesiss to summarise findings from uncontrolled or non-randomised studies, however for 
ease of interpretation we decided to instead perform meta-analysis where possible, limiting 
the use of narrative synthesis to outcomes where we had only one or two studies. 
 
2.3.Data Extraction and Outcomes 
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In line with previous meta-analyses (Kohler et al., 2009; Kurtz & Richardson, 2012) different 
measures of facial affect identification and discrimination were included and combined given 
the assumed similarity of the task of labelling emotional expressions and distinguishing 
emotional expressions between two different faces. These included the Facial Emotion 
Identification Test (FEIT), Vienna Emotion Recognition Task (VERT-K), Pictures of Facial 
Affect (PFA) and an Emotion Matching Task. Many of these measures are based on the 
Ekman pictures of facial affect (Ekman & Friesen, 1976) making their results comparable. 
Only studies using these or other valid and reliable measures of facial affect recognition were 
eligible for inclusion. For the outcomes of psychotic symptoms and social functioning, a 
scoping review suggested there may be limited data. In order to be as inclusive as possible, 
no a priori decisions were made regarding preferred measures aside from the requirement that 
they have established reliability and validity. For symptoms, included data could be mean 
change or endpoint data from the PANSS or the BPRS or any other reliable and valid 
measure of symptoms as used by study authors. Authors were contacted in the event of 
missing data. If means or standard deviations were not reported and not obtainable, then 
where possible we derived estimates of the between and within-group effect size from other 
statistical parameters, including confidence intervals, standard errors, p-values, t-values 
and/or f-values, following procedures outlined in the Cochrane Handbook (Higgins et al., 
2011). 
 
2.4.Meta-Analysis Calculations 
If studies had two or more FRT arms (or two or more usable control group arms), then these 
were combined into one using procedures outlined in the Cochrane Handbook (Higgins et al., 
2011). For each meta-analysis of between group differences, means and associated standard 
deviations were entered into MetaXL (Barendregt & Doi, 2016), which computed a pooled 
standardised mean difference (Hedges’s g) and 95% confidence interval. A random effects 
model was used, since this assumes the true effect size can vary across studies (Borenstein et 
al., 2009), and that the individual effect sizes are a random sample from the distribution of 
possible effects. The heterogeneity of the effect sizes was measured using the I
2
 statistic, and 
a Chi-Square test was performed to evaluate if the intervention effects vary more than could 
be expected due to random error only. Similar procedures were followed for meta-analyses of 
within-group change. 
 
2.5. Risk of Bias and Study Quality 
The Cochrane Collaboration Risk of Bias Tool (Higgins et al., 2011) was used to assess the 
methodological quality of the randomised controlled trials included in the meta-analysis. It 
involves examining a range of biases that can occur in trials such as how participants are 
randomised, blinding of both participants and study personnel and selective reporting of 
results. Each feature of interest is given a rating of either ‘low’, ‘high’ or ‘unclear’ risk of 
bias and these ratings are then taken into account when interpreting the effect sizes of the 
outcomes and subsequently the conclusions that can be made from the data. The quality of 
the overall meta-analytical estimates was assessed using the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) (Guyatt et al., 2011). GRADE rates the 
quality of the evidence across studies and is an effective method of linking evaluations of the 
quality of the evidence to clinical recommendations. 
 
For the non-randomised studies, a tool developed by the Agency for Healthcare Research and 
Quality (AHRQ, 2012) was used to assess the quality of the studies. This tool is 
recommended by the Centre for Reviews and Dissemination (CRD, 2009) as suitable for 
assessing the quality of observational studies and it is advised that the tool should be adapted 
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for the individual requirements of the systematic review. An adapted version of the AHRQ 
tool was therefore used which included the domains of selection bias, detection bias, 
statistical power, validity of measures and method of analysis. Each item was rated using the 
tool and assigned a rating of either ‘yes’, ‘no’, ‘partially’, ‘or unclear’. 
  
3. Results 
 
3.1.Study Selection 
Figure 1 outlines the process of study selection. The initial search, after removal of 
duplicates, identified 2439 papers, conference abstracts and dissertations. The majority of 
these papers were discarded on the basis of their title or abstract where it was clear that they 
did not involve treatment programmes for facial affect recognition, or did not include people 
with psychosis. The full text of 44 papers were reviewed in detail, and from these 12 papers 
were identified as suitable for inclusion. One further paper was identified from the reference 
section of these included studies bringing the total to 13. Eight were randomised controlled 
trials, 4 were correlational studies and 1 used a healthy matched control group design.  
 
3.2.Study Characteristics 
A total of 8 studies involving 300 participants were included in the meta-analysis of the effect 
of FRT on facial affect recognition ability. As shown in Table 1, a range of FRT programmes 
were assessed. These included Training of Affect Recognition, Attentional Shaping, Micro-
Expression Training Tool and Facial Feedback. All programmes were solely focused on 
improving facial affect recognition, but varied in duration from 1 treatment session to 12 
sessions. Control group participants received various interventions, including cognitive 
remediation therapy, repeated exposure to pictures of facial affect, or simply treatment as 
usual. 
 
3.3.Outcomes from randomised controlled trials 
 
3.3.1. Facial affect recognition 
An analysis of post-intervention data from all 8 RCTs (300 participants) found a very large 
effect of FRT on facial affect recognition ability [g=1.26, 95% CI 0.92, 1.60; see Figure 2 
(a)]. This estimate was judged to be low in quality primarily because the studies were small 
and generally at high or unclear risk of various forms of bias, including lack of information 
about generation of allocation sequences or use of rater blinding. Although the overall sample 
size (N=300) had adequate power to detect effects of moderate magnitude, and although the 
reported effects were very large, sample sizes of less than 400 are generally considered to 
produce fragile estimates (Guyatt et al., 2011). 
 
Three studies (108 participants) reported data at 1-week following the intervention. As shown 
in Figure 2 (b), a large significant effect was found (g=1.46, 95% CI 0.61, 2.32). Although 
there was considerable heterogeneity (I
2
= 72%), it should be noted that all studies reported 
large effects. Nonetheless, the risk of bias in the included studies and the small overall 
sample size meant the estimate was judged to be low in quality.  
 
A third analysis was carried out of studies comparing FRT to interventions which controlled 
for potential non-specific effects of additional therapeutic attention and time [see Figure 2 
(c)]. These interventions included repeated exposure to pictures of facial affect or Cognitive 
Remediation Training (CRT). Comparisons involving waiting list or usual treatment groups 
were excluded from this analysis. This calculation was based on 5 studies and included data 
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for 198 participants. A large significant effect was found (g=1.45, 95% CI 0.98, 1.92, I
2
 
72%), but risk of bias and small overall sample size meant the overall estimate was rated as 
low in quality.  
 
3.3.2. Psychotic symptoms 
As shown in Figure 3, no significant benefits of FRT were found for negative symptoms 
(k=4; g= -0.11, 95% CI -0.41, 0.20), positive symptoms (k=3; g=0.10, 95% CI -0.25, 0.45) or 
general psychopathology (k=3; g=0.12, 95% CI -0.44, 0.69). The confidence intervals for 
each estimate include the possibility of both small to moderate benefits and small to moderate 
harms. This, together with the risk of bias in the trials included in the analyses meant each of 
these estimates were rated as very low quality. 
 
3.3.3. Social Functioning 
A large effect of the facial affect recognition interventions on social functioning emerged 
from a meta-analysis of data from 3 trials (k=3, N=114, g=0.87, 95% CI 0.37, 1.36, I
2 
38%), 
however a high risk of bias in these trials and their small sample size meant this estimate was 
rated as low in quality. 
 
3.4. Outcomes from non-randomised or uncontrolled trials 
 
3.4.1. Facial affect recognition ability 
Seven groups of participants from 5 non-randomised controlled trials provided data on the 
association over time between facial affect recognition ability and exposure to facial affect 
recognition training. Reported associations ranged from moderate in magnitude to very large. 
However all studies were small, meaning their individual estimates were generally very 
imprecise. To facilitate accurate interpretation, a post-hoc meta-analysis was carried out; this 
suggested facial affect recognition training was associated with a large improvement in facial 
affect recognition ability (k=7, N=106, Cohen’s d=0.95, 95% CI 0.52, 1.38), although there 
was considerable variance in estimates of exactly how large this association was (I
2 
68%). 
There was very limited follow-up data from these studies. 
 
3.4.2. Psychotic symptoms  
Data on the association over time between facial affect training and psychotic symptoms was  
limited and conflicting. One small study (Frommann et al., 2003; N=16) reported significant 
improvements in positive, negative and general psychotic symptoms after participants 
received 12 sessions of training, whereas a comparable study  (Drusch et al., 2014; N=16; 12 
sessions) reported no change in any symptom domain. None of the studies included in this 
section reported additional data on social functioning. 
 
4. Discussion  
 
There is compelling evidence that patients with a diagnosis of schizophrenia have a large and 
specific difficulty in recognising facial affect (Kohler et al., 2009). This difficulty is 
associated with both psychotic symptoms (Ventura et al., 2013) and impaired social 
functioning (Hooker & Park, 2002; Irani et al., 2012). It precedes the development of 
psychotic symptoms (Gibson et al., 2010), and persists despite successful antipsychotic 
treatment (Addington & Addington, 1998). The potential significance of this particular 
impairment has encouraged several research groups to develop targeted interventions to 
improve it. Our meta-analytical synthesis of randomised controlled trials of these 
interventions suggests that they are highly efficacious. Although existing studies are small, 
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very large improvements in facial affect recognition were also demonstrated in those trials 
which controlled for non-specific effects of additional therapist time and attention. We also 
found early evidence that facial affect recognition training may have large effects on real-
world social functioning. Although there do not appear to be immediate effects on psychotic 
symptoms of these improvements, the apparent malleability of facial affect recognition is 
welcome news for people with psychosis, and offers considerable encouragement to those 
trying to develop ways of altering their adverse social trajectory.  
 
One particularly influential theory proposes that psychosis develops in response to repeated 
experiences of social defeat (Selten et al., 2013). This theory helps to account for the well-
established findings that childhood adversity (Varese et al., 2012), migration, urbanicity and 
discrimination (Selten et al., 2013) are each associated with an increased risk of psychosis, 
and as well as the more recent finding that adult trauma survivors have an increased risk of 
developing psychosis (Okkel et al., 2016). A recent iteration of the neurodevelopmental 
hypothesis endorses this theory (Howes & Murray, 2014), which suggests that social defeat 
may lead to sensitisation of the dopaminergic neurotransmitter system, which in turn may 
cause changes in the perceived importance or salience of normally innocuous environmental 
stimuli. Howes and Murray (2014) attempt to integrate this with the perspective offered by 
cognitive models of psychosis (Garety et al., 2001; Morrison, 2001), that delusions develop 
as the affected individual tries to make sense of these and other odd, intrusive, experiences, 
and that this meaning-making process is strongly influenced by pre-existing schemata as well 
as specific cognitive processing biases.  
 
Surprisingly, the significant associations between facial affect recognition difficulties and 
psychotic symptoms (Kohler et al., 2009; Ventura et al., 2013) are not discussed in any of 
these models, despite clear associations between emotion perception skills and social defeat-
like risk factors for psychosis, including trauma and migration. There is good evidence that 
emotion recognition is impaired in children who experience early adversity (see Pollack, 
2006, for overview) or relational bullying from peers (Woods et al., 2009) or are adopted and 
raised in a country they were not born in (Hwa-Froelich et al., 2014). Migrants are known to 
have an increased risk of psychosis, and there is evidence that adult migrants also have 
relatively lower accuracy (Derntl et al., 2009) and confidence in emotion recognition 
(Beaupré & Hess, 2006), although both grow as duration of stay in the host culture increases 
(Derntl et al., 2009; Beaupré & Hess, 2006). It is highly plausible that not being able to 
accurately identify emotions may leave individuals struggling to navigate the complexities of 
social interaction and therefore vulnerable to social defeat-like experiences. Indeed, a relative 
inability to understand the motives of others may not only reduce one’s chances of achieving 
valued goals such as employment, relationships, and friendships, it may also make a person 
more vulnerable to exploitation by those with hostile intent. Difficulty interpreting social 
cues such as facial affect may also generate puzzling experiences, in that not knowing how 
others are feeling may make it difficult to predict or explain their subsequent actions, which 
may fuel paranoia and distrust.  
 
Our finding that FRT consistently rectifies this impairment is therefore a welcome one, and 
the observed improvements in social functioning also raises the hope that this relatively 
simple intervention may also increase the capacity of individuals with psychosis to 
experience social success, rather than defeat. Although no parallel improvement in symptoms 
was observed in those who received FRT, the few studies that measured psychotic symptoms 
did so soon after the intervention, and a longer follow-up period of time may be required 
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before symptomatic improvement occurs. Equally, researchers may consider using measures 
that are more sensitive to early, perhaps subtle, evidence of change in symptoms. 
 
4.1.Limitations 
 
The trials we reviewed suffered from a number of difficulties. Little information on 
randomisation procedures (eg sequence generation, allocation concealment) were provided, 
and the majority of the studies did not report whether assessors were blind to group 
allocation. The quality of the non-RCT studies was also reduced by small sample sizes and 
partial reporting of selection processes. Future trials should therefore ensure that not only are 
adequate randomisation procedures and blinding of participants and personnel carried out, but 
that this is reported in any publications in line with the recommendations of the CONSORT 
criteria (Schulz et al., 2010). While all of the studies and indeed the final analysis 
demonstrated positive results of the various programmes on facial affect recognition, given 
the small sample sizes considerable caution must be taken when interpreting these results. In 
accordance with the GRADE approach, the meta-analytical estimates were assessed as low 
quality for the primary outcome of improvement in facial affect recognition, low quality for 
social functioning, and very low quality for psychotic symptoms - largely because of the risk 
of bias in the included studies. There were also too few studies to assess for the presence of 
publication bias (Higgins et al., 2011; Ioannidis & Trikalinos, 2007). Although future meta-
analyses may be able to address this question, pre-registration of RCTs and other studies in 
clinical trial registries will aid assessment of this.  
 
4.2.Conclusion 
Many individuals with psychosis struggle to identify the emotions of other people, which 
may have a negative impact on their ability to experience social success and wellbeing. There 
is also good reason to think this well-established difficulty may exacerbate psychotic 
symptoms, either indirectly via social defeat or directly via the generation of confusing 
interpersonal experiences. The evidence we have synthesised here suggests that this difficulty 
can be easily and effectively ameliorated with a simple psychological intervention. Although 
there are problems with the quality of this evidence, this no doubt reflects the early stage of 
work in this area. Although social functioning seemed to improve following FRT, the null 
findings with respect to psychotic symptoms underlines the fact that we cannot take it for 
granted that these interventions actually do have transferable or meaningful benefits. If 
established psychosis lies at the end of an adverse social trajectory, then perhaps we need to 
offer these interventions at a much earlier stage in order to see meaningful change? We urge 
trialists to begin to measure and report data which will allow us to answer this and other 
related questions regarding the benefits and costs of facial affect recognition training in 
psychosis. 
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Figure 1. Search Process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of record identified 
through database searching: 
3954 
Number of records after 
duplicates removed: 
2439 
 
Number of records screened 
(abstract/description): 
318 
 
Number of records 
excluded on basis of title: 
2121 
Number of full text reports 
screened for eligibility: 
44 
 
Number of studies included in 
the review: 
13 
Number of records 
excluded on abstract: 
274 
Number of full text reports 
excluded: 
32 
28 Less than 50% of 
intervention directly targeting 
FAR 
3 Not specifically targeting 
FAR 
1 not intervention trial 
 
Number of studies 
identified from reference 
section for inclusion: 
1 
Number of non-randomised or 
uncontrolled trials:  
5 
Number of randomised 
controlled trials:  
8 
Facial affect recognition and schizophrenia 
Table 1. Study Characteristics 
Trial Treatments N 
Maximum 
duration of 
treatment  
(N sessions) 
FAR measures 
Additional 
measures 
Inpatients 
Age (years) 
mean (sd) 
Female N 
(%) 
Follow up 
 
         
Randomised controlled trials (k=8) 
       
Penn & Combs.  
(2000) 
Monetary 
reinforcement and 
facial feedback 
9 1 Face Emotion 
Identification Test 
(FEIT); Facial 
Emotional 
Discrimination 
Task (FEDT) 
 100% 38.3 (6.04) 44% 1 week 
 Monetary feedback 
only 
12     40.42 (6.08) 42%  
 Facial feedback only 9     39.1 (8.3) 33%  
 Repeated exposure/ 
active control 
10     41.5 (12) 50%   
Russell et al., (2008) Micro-expression 
training tool (METT) 
26 1 EMT (emotion 
matching task) pre 
and post 
 0% 40 (10) 35% 1 week 
 Repeated exposure/ 
active control 
14     44 (9) 29%   
Sachs et al., (2012) Training of Affect 
Recognition (TAR) 
20 12 Vienna Emotion 
Recogntion Task 
(VERT-K) 
PANSS neg. 
pre and post 
Both (no 
figures 
given) 
27.2 (7.17) 40% none 
 TAU 18     37.72 (9.35) 55%   
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Trial Treatments N 
Maximum 
duration of 
treatment  
(N sessions) 
FAR measures 
Additional 
measures 
Inpatients 
Age (years) 
mean (sd) 
Female N 
(%) 
Follow up 
 
         
Wolwer & 
Frommann (2011) 
Training of Affect 
Recognition (TAR) 
20 12 Pictures of Facial 
Affect 
Social and 
Occupational 
Functioning 
Assessment 
(SOFAS); 
PANSS pre 
and post 
100% 36.7 (13.1) 32% none 
 Cognitive 
Remediation Therapy 
(CRT) 
18         
Wolwer  et al., 
(2005) 
Training of Affect 
Recognition (TAR) 
28 12 Pictures of Facial 
Affect 
PANSS pre 
and post 
75% 31.5 (6.9) 11% none 
 Cognitive 
Remediation Therapy 
(CRT) 
24     36.7 (11.4) 42%  
 TAU 25     35.2 (11.1) 16%   
Combs et al., (2008) Attentional Shaping 20 1 Face Emotion 
Identification Test 
(FEIT); Bell-
Lysaker Emotion 
Recogntion Test 
(BLERT) 
 100% 38.7 (13.7) 35% 1 week 
 Monetary 
Reinforcement 
20        
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Trial Treatments N 
Maximum 
duration of 
treatment  
(N sessions) 
FAR measures 
Additional 
measures 
Inpatients 
Age (years) 
mean (sd) 
Female N 
(%) 
Follow up 
 
         
 Repeated exposure/ 
active control 
20         
Habel et al (2010) Training of Affect 
Recognition (TAR) 
10 12 Emotion 
identification task 
PANSS pre 
and post 
Both (no 
figures 
given) 
31.4 (7.8) 0% none 
 TAU 10     33.7 (10.65)    
Luckhaus et al 
(2013) 
Training of Affect 
Recognition (TAR) 
10 12 Pictures of Facial 
Affect (PFA); 
Event-related 
potentials (ERP); 
HCR-20; 
PANSS pre 
measures only 
given 
100% 35.3 (8.2) 0% 2 months 
 Waiting list control 9         
Non-randomised or non-controlled trials (k=5)        
Combs et al (2011) Attentional Shaping 15 5 Face Emotion 
Identification Test 
(FEIT); Bell-
Lysaker Emotion 
Recogntion Test 
(BLERT) 
none 0% 39.0 (10.9) 40% none 
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Trial Treatments N 
Maximum 
duration of 
treatment  
(N sessions) 
FAR measures 
Additional 
measures 
Inpatients 
Age (years) 
mean (sd) 
Female N 
(%) 
Follow up 
 
         
Drusch et al (2014) Training of Affect 
Recognition (TAR) 
16 12 Karolinska 
Directed 
Emotional Faces 
(KDEF); eye-
tracking 
PANSS pre 
and post 
100% 36.9 (11.67) 25% none 
Frommann et al 
(2003) 
Training of Affect 
Recognition (TAR) 
16 12 Pictures of Facial 
Affect (PFA) 
PANSS pre 
and post 
not reported 31.9 (7.3) 19% none 
Marsh et al. (2010) Micro-expression 
training tool (METT) 
39 4 METT faces; 
Pictures of Facial 
Affect (POFA); 
TASIT 
none 31% inpatient= 
31.92 (7.31); 
outpatient= 
41.19 (9.38) 
28% 1 month 
Russell et al., (2006) 
 
Micro-expression 
training tool (METT) 
20 1 EMT (emotion 
matching task) pre 
and post; 
Microexpressions 
of emotions pre 
and post 
none 0% 38.05 (7.91) 
 
55% none 
 Healthy matched 
controls 
20        
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Figure 2(a). The effect of facial affect recognition training on recognition of facial affect 
at post-intervention, compared to usual care or inactive control 
 
 
 
 
 
 
 
 
Figure 2(b) The effect of facial affect recognition training on recognition of facial affect 
at 1-week follow up, compared to usual care or inactive control 
  
 
 
 
 
 
 
Figure 2 (c) The effect of facial affect recognition training on recognition of facial affect 
at post-intervention, compared to inactive control only 
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Figure 3 (a) The effect of facial affect recognition training on negative symptoms at 
post-intervention, compared to usual care or inactive control 
 
   
 
 
 
 
 
Figure 3 (b) The effect of facial affect recognition training on positive symptoms at post-
intervention, compared to usual care or inactive control 
 
  
 
 
 
 
 
Figure 3 (c) The effect of facial affect recognition training on general psychopathology 
at post-intervention, compared to usual care or inactive control 
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Figure 4. The effect of facial affect recognition training on social functioning at post-
intervention or follow-up, compared to usual care or inactive control 
 
 
 
 
 
 
Figure 5. The association between facial affect recognition training and facial affect 
recognition ability in non-randomised or uncontrolled studies 
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Table 2. Summary of meta-analytical estimates (randomised controlled trials only) 
Outcome 
No. of treatment 
sessions 
No. of included 
studies 
Intervention, n Control, n 
Hedges g (95% 
CI) 
Heterogeneity Quality 
        
FAR improvement, post-
intervention  
1-12 8 152 148 1.26 (0.92, 1.60) I²= 41% Low 
FAR improvement, 1-week 
follow up 
1 3 64 44 1.46 (0.60, 2.31) I²= 72% Low 
FAR improvement vs inactive 
control group, post-treatment 
1-12 5 112 86 1.45 (0.98, 1.92) I²= 54% Low 
Improvement in negative 
symptoms, post-treatment 
12 4 78 95 -0.11 (-0.41, 0.20) I²= 0% Very low 
Improvement in positive 
symptoms, post-treatment 
12 3 58 77 0.10 (-0.25, 0.45) I²= 0% Very low 
Improvement in general 
psychopathology, post-
treatment 
12 3 58 77 0.12 (-0.44, 0.69) I²=56% Very low 
Improvement in social 
functioning, post-treatment or 
follow-up 
1-12 3 59 55 0.87 (0.37, 1.36) I
2
=38% Low 
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Table 3. Risk of bias ratings for randomised controlled trials 
Study 
Random 
sequence 
generation 
(selection 
bias) 
Allocation 
concealment 
(selection 
bias) 
Blinding of 
participants 
and personnel 
(performance 
bias) 
Blinding of 
outcome 
assessment 
(detection 
bias) 
Incomplete 
outcome data 
addressed 
(attrition 
bias) 
Incomplete 
outcome data 
addressed 
(attrition bias) 
(Follow-up) 
Selective 
reporting 
(reporting bias) 
        
Combs 2008 Unclear  Unclear  High High Low  Low  Low 
Habel 2010 Unclear Unclear  High  High High N/A Low 
Luckhaus 2013 Unclear Unclear High High High High Low 
Penn 2000 Unclear Unclear High High Low High Low 
Sachs 2012 Low High High High High N/A Low 
Russell 2008 Unclear Unclear High High Low High Low 
Wolwer 2005 Unclear Unclear High High Low N/A Low 
Wolwer 2011 Unclear Unclear High Low High N/A High 
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Table 4. GRADE assessment of meta-analytical estimates 
Outcome Quality Inconsistency Indirectness Imprecision 
Publication 
Bias 
Other 
factors 
Overall 
        
FAR improvement after 
intervention 
-2 0 0 -1 0 +1 1 (Low) 
FAR improvement at 
follow up 
-2 0 0 -1 0 +1 1 (Low) 
FAR improvement vs 
active control group 
-2 0 0 -1 0 +1 1 (Low) 
Improvement in negative 
symptoms 
-2 0 0 -1 0 0 (0) Very 
low 
Improvement in positive 
symptoms 
-2 0 0 -1 0 0 (0) Very 
low 
Improvement in general 
psychopathology 
-2 -1 0 -1 0 0 (0) Very 
low 
Improvement in social 
functioning 
-2 0 0 -1 0 +1 (1) Low 
        
Note: For assessment of outcome quality, 1 point was deducted if >50% of studies contributing to that outcome had at least one ‘high risk’ rating according to 
the Cochrane Risk of Bias assessment and 2 points if >50% of studies has at least two ratings of ‘high risk’. For inconsistency, a study was downgraded by 1 
point if the I² statistic was >40% in the context of an unclear direction of effect or >75% in the context of a clear direction of effect. If the I² statistic was 
>75% in the context of no clear direction of effect, a downgrade of 2 points was made. For imprecision, an outcome was downgraded if “a recommendation 
or clinical course of action would differ if the upper versus the lower boundary of the CI represented the truth”(Guyatt et al., 2011). An outcome was 
upgraded by 1 point if a very large effect size was found (Higgins et al., 2011).      
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Table 5. Summary of findings from observational studies 
Outcome Study 
Pre-treatment mean 
(sd) 
Post-treatment mean 
(sd) 
Reported results 
Cohen’s d  
(95% CI ) 
      
Facial affect recognition 
ability at end of 
treatment 
Combs 2011 1 session (N=6) 10.60 
(1.20) 
11.30 (1.80)  d=0.38
2 
(-0.47, 1.20) 
3 sessions (N=4) 
11.70 (1.20)  
12.70 (2.20)  d=0.46
2
 (-0.61, 1.47) 
5 sessions (N=5) 9.40 
(2.80) 
14.40 (1.90)  d=1.74
2
 (0.26, 3.16) 
Drusch 2014 
(N=16) 
68.00 (8.00) 77.00 (10.00) t= -3.50, p=0.003 d=0.87
2
 (0.28, 1.44) 
Frommann 2003 
(N=16) 
17.06 (2.75)  20.00 (3.10) t= -5.26, p<0.001 d=1.31
3
 (0.62, 1.97) 
Marsh 2010 (N=39) 75.00 (not reported) 93.00 (not reported) t=-10.01, p<0.005 d=1.60
3
 (1.12, 1.92 
Russell 2006 
(N=20) 
75.60 (11.78)  79.50 (9.21) t=2.05, p<0.02 d=0.46
3
 (-0.01, 0.92) 
Facial affect recognition 
ability at follow-up 
Marsh 2010 (1 
month) (N=10) 
Not reported Not reported t=-6.69, p<.0005 d=1.84
4
 (0.78, 2.86) 
Positive symptoms Drusch 2014 
(N=16) 
12.50 (4.23) 12.00 (4.71)  d=-0.09
2
 (-0.58, 0.40) 
Frommann 2003 
(N=16) 
13.80 (6.40) 10.10 (2.90) t=2.63, p<0.02 d=-0.66
3
 (-1.19,  -
0.11) 
Negative symptoms Drusch 2014 
(N=16) 
11.90 (4.49) 12.20 (6.89)  d=0.04
2
 (-0.45, 0.53) 
Facial affect recognition and schizophrenia 
Outcome Study 
Pre-treatment mean 
(sd) 
Post-treatment mean 
(sd) 
Reported results 
Cohen’s d  
(95% CI ) 
      
Frommann 2003 
(N=16) 
21.10 (7.80) 16.60 (6.70) t=3.67, p<0.003 d=-0.92
3
 (-1.50, -0.32) 
General 
psychopathology 
Drusch 2014 
(N=16) 
25.90 (6.17)  26.50 (6.49)  d=0.08
2
 (-0.41, 0.57) 
Frommann 2003 
(N=16) 
33.20 (9.90) 24.70 (3.50) t=3.94, p<0.001 d=-0.98
3
 (-1.57, -0.37) 
      
1
Confidence intervals for Cohen’s d were calculated using the procedures outlined in Cumming and Finch (2001); 2Based on an estimated moderate 
correlation of 0.3 between pre and post means; 
3
Computed as difference in means divided by standard deviation of difference in means. The latter was derived 
from reported t-test values: SD of mean difference = (difference in means / t) x √N; 4As reported in paper.  
  
Facial affect recognition and schizophrenia 
Table 6. Quality ratings for observational studies 
Study 
Unbiased 
selection 
of cohort 
Selection minimises 
baseline differences 
in prognostic factors 
Sample size 
justification 
report 
Sufficient 
power 
Adequate 
description 
of the 
cohort 
Validated method 
for measuring 
facial affect 
recognition 
Outcome assessment 
blind to exposure 
Analytic 
methods 
appropriate 
         
Frommann 2003 No Can’t tell No No No   Partially Can’t tell Partially 
Drusch 2014 Partially Partially No No Yes Partially Can’t tell Partially 
Marsh 2010 Partially Can’t tell No No Yes Partially Can’t tell Partially 
Combs 2011 Partially Partially No No Yes  Partially Can’t tell Partially 
Russell 2006 Partially Yes  No No Yes Partially Can’t tell Partially 
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